167 related articles for article (PubMed ID: 29379163)
1. c-Src activity is differentially required by cancer cell motility modes.
Logue JS; Cartagena-Rivera AX; Chadwick RS
Oncogene; 2018 Apr; 37(16):2104-2121. PubMed ID: 29379163
[TBL] [Abstract][Full Text] [Related]
2. SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60(c-Src)-dependent tyrosine phosphorylation of beta-catenin and its nuclear signaling.
Coluccia AM; Benati D; Dekhil H; De Filippo A; Lan C; Gambacorti-Passerini C
Cancer Res; 2006 Feb; 66(4):2279-86. PubMed ID: 16489032
[TBL] [Abstract][Full Text] [Related]
3. The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism.
Franzen CA; Amargo E; Todorović V; Desai BV; Huda S; Mirzoeva S; Chiu K; Grzybowski BA; Chew TL; Green KJ; Pelling JC
Cancer Prev Res (Phila); 2009 Sep; 2(9):830-41. PubMed ID: 19737984
[TBL] [Abstract][Full Text] [Related]
4. The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1.
Liu W; Yue F; Zheng M; Merlot A; Bae DH; Huang M; Lane D; Jansson P; Lui GY; Richardson V; Sahni S; Kalinowski D; Kovacevic Z; Richardson DR
Oncotarget; 2015 Apr; 6(11):8851-74. PubMed ID: 25860930
[TBL] [Abstract][Full Text] [Related]
5. SKI-606, an Src inhibitor, reduces tumor growth, invasion, and distant metastasis in a mouse model of thyroid cancer.
Kim WG; Guigon CJ; Fozzatti L; Park JW; Lu C; Willingham MC; Cheng SY
Clin Cancer Res; 2012 Mar; 18(5):1281-90. PubMed ID: 22271876
[TBL] [Abstract][Full Text] [Related]
6. Src activation regulates anoikis in human colon tumor cell lines.
Windham TC; Parikh NU; Siwak DR; Summy JM; McConkey DJ; Kraker AJ; Gallick GE
Oncogene; 2002 Nov; 21(51):7797-807. PubMed ID: 12420216
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of STAT3, FAK and Src mediated signaling reduces cancer stem cell load, tumorigenic potential and metastasis in breast cancer.
Thakur R; Trivedi R; Rastogi N; Singh M; Mishra DP
Sci Rep; 2015 May; 5():10194. PubMed ID: 25973915
[TBL] [Abstract][Full Text] [Related]
8. Involvement of c-Src in carcinoma cell motility and metastasis.
Sakamoto M; Takamura M; Ino Y; Miura A; Genda T; Hirohashi S
Jpn J Cancer Res; 2001 Sep; 92(9):941-6. PubMed ID: 11572761
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
[TBL] [Abstract][Full Text] [Related]
10. Displacement of p130Cas from focal adhesions links actomyosin contraction to cell migration.
Machiyama H; Hirata H; Loh XK; Kanchi MM; Fujita H; Tan SH; Kawauchi K; Sawada Y
J Cell Sci; 2014 Aug; 127(Pt 16):3440-50. PubMed ID: 24928898
[TBL] [Abstract][Full Text] [Related]
11. Novel insights into c-Src.
Alper O; Bowden ET
Curr Pharm Des; 2005; 11(9):1119-30. PubMed ID: 15853660
[TBL] [Abstract][Full Text] [Related]
12. Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines.
Eustace AJ; Crown J; Clynes M; O'Donovan N
J Transl Med; 2008 Sep; 6():53. PubMed ID: 18823558
[TBL] [Abstract][Full Text] [Related]
13. MUC1 initiates Src-CrkL-Rac1/Cdc42-mediated actin cytoskeletal protrusive motility after ligating intercellular adhesion molecule-1.
Shen Q; Rahn JJ; Zhang J; Gunasekera N; Sun X; Shaw AR; Hendzel MJ; Hoffman P; Bernier A; Hugh JC
Mol Cancer Res; 2008 Apr; 6(4):555-67. PubMed ID: 18403635
[TBL] [Abstract][Full Text] [Related]
14. Src family kinases are required for integrin but not PDGFR signal transduction.
Klinghoffer RA; Sachsenmaier C; Cooper JA; Soriano P
EMBO J; 1999 May; 18(9):2459-71. PubMed ID: 10228160
[TBL] [Abstract][Full Text] [Related]
15. Integrin αvβ3 expression in tongue squamous carcinoma cells Cal27 confers anticancer drug resistance through loss of pSrc(Y418).
Stojanović N; Brozovic A; Majhen D; Bosnar MH; Fritz G; Osmak M; Ambriović-Ristov A
Biochim Biophys Acta; 2016 Aug; 1863(8):1969-78. PubMed ID: 27108184
[TBL] [Abstract][Full Text] [Related]
16. Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates.
Yamazaki D; Kurisu S; Takenawa T
Oncogene; 2009 Apr; 28(13):1570-83. PubMed ID: 19234490
[TBL] [Abstract][Full Text] [Related]
17. v-Src's hold over actin and cell adhesions.
Frame MC; Fincham VJ; Carragher NO; Wyke JA
Nat Rev Mol Cell Biol; 2002 Apr; 3(4):233-45. PubMed ID: 11994743
[TBL] [Abstract][Full Text] [Related]
18. Kinase-dependent adhesion to fibronectin: regulation by calreticulin.
Papp S; Szabo E; Kim H; McCulloch CA; Opas M
Exp Cell Res; 2008 Apr; 314(6):1313-26. PubMed ID: 18255058
[TBL] [Abstract][Full Text] [Related]
19. Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways.
Bouchard V; Demers MJ; Thibodeau S; Laquerre V; Fujita N; Tsuruo T; Beaulieu JF; Gauthier R; Vézina A; Villeneuve L; Vachon PH
J Cell Physiol; 2007 Sep; 212(3):717-28. PubMed ID: 17443665
[TBL] [Abstract][Full Text] [Related]
20. Met-induced membrane blebbing leads to amoeboid cell motility and invasion.
Laser-Azogui A; Diamant-Levi T; Israeli S; Roytman Y; Tsarfaty I
Oncogene; 2014 Apr; 33(14):1788-98. PubMed ID: 23665680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
